Home » Topics » BioWorld Science

BioWorld Science
RSS

New influenza vaccine prepared by Yissum

June 6, 1997

Agents for HIV, tumors and autoimmune diseases from Boehringer Mannheim

June 6, 1997

Fibrinogen antagonists from Merck & Co.

June 6, 1997

Preparation and use of 5alpha-reductase type 1 inhibitors described by Merck & Co.

June 6, 1997

Takeda describes GnRH antagonists

June 6, 1997

Fujisawa discloses agents for bone metabolism disorders

June 6, 1997

Maxygen: new biotechnology company

June 6, 1997

Schering-Plough Research Institute reveals structure of enzyme in HCV life cycle

June 6, 1997

Immunex reports anticancer activity of Flt3 ligand

June 6, 1997

FDA approves generic version of Diamox

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...